Jennison Associates
GYRE icon

Jennison Associates’s Gyre Therapeutics GYRE Stock Holding History

Jennison Associates’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-704
Closed -$1.4M – 736
2014
Q3 		$1.4M Sell
704
-62
-8% -$153K ﹤0.01% 615
2014
Q2 		$2.72M Sell
766
-122
-14% -$398K ﹤0.01% 545
2014
Q1 		$3.32M Buy
888
+3
+0.3% +$11.1K ﹤0.01% 549
2013
Q4 		$2.89M Buy
885
+3
+0.3% +$11.8K ﹤0.01% 542
2013
Q3 		$3.69M Hold
882
– – ﹤0.01% 520
2013
Q2 		$2.97M Buy
+882
New +$3.36M ﹤0.01% 510

Other funds holding GYRE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return